In vivo cell electropermeabilization can be used alone or in combination with a hydrophilic, nonpermeant cytotoxic drug such as bleomycin (electrochemotherapy) to efficiently treat tumors. We used magnetic resonance imaging to detect rapid structural modifications in tumors treated by electroporation-based methods. Water diffusion coefficient (ADC), transverse relaxation time (T 2 ) and tumor volume of fibrosarcomas xenografted on syngenic mice were measured upon 3 groups of 6 treated mice within the 48 hrs following ECT done with a normal (BE) or a high dose of bleomycin (HBE), and after irreversible electroporation (IRE), and in three control groups. As expected, the tumor volume increased in the control groups at 48 hrs (p , 0.05) and the values of ADC and T2 did not varied significantly in the control groups except for ADC decrease and T2 increase observed between 3 hrs and 24 hrs (p , 0.03) in the group that received bleomycin only. Tumor volumes decreased significantly at 24 hrs in the IRE and HBE groups. The mean tumor ADC increased significantly at 24 hrs (117.6%, p , 0.03) in the BE group, probably reflecting apoptosis, while in the HBE group the mean tumor ADC increased earlier, at 10 hrs (119%, p , 0.03) because of the speed of the pseudoapopototic process. In the IRE group, the mean tumor ADC decreased significantly at 1 hrs (p , 0.05) and 3 hrs (p , 0.03), and T 2 decreased (p , 0.03), both probably reflecting cell swelling induced by the vascular lock. Thus ADC and T 2 changes in the treated tumors correlated with previous histological observations on the same tumor models. Noteworthy, ADC allowed the visualization of early and rapid changes in the treated tumors, when tumor volume monitoring was not yet able to detect any effect of the treatments.
Introduction
Electropermeabilization is widely used, in-vitro and in-vivo, for the introduction of various nonpermeant molecules: dyes, oligonucleotides, DNA, radiotracers, pro� pro� teins and drugs into living cells (1, 2) . Indeed, at adequate levels of the electric field pulses amplitude, an induced transmembrane potential change results in the transient permeabilization of the cell membrane that provides a direct access of molecules to the cytosol, and to the nucleus. Electrochemotherapy (ECT) is a new safe and efficient local treatment of tumors that combines in vivo cell electroperme� abilization with hydrophilic, nonpermeant cytotoxic drugs. These drugs are unable Technology in Cancer Research & Treatment, Volume 11, Number 6, December 2012 to diffuse through the plasma membrane of intact cells, thus entering the cells through the electropermealized areas.
ECT increases the cytotoxicity of some anticancer drugs like cisplatin (3) or bleomycin (4) by respectively, one or three orders of magnitude. This makes possible to largely increase the efficacy of these molecules using classical dosages devoid of side effects. Bleomycin acts as a miniendonuclease, active on all cell types, and kills the electropermeabilized cells by mitotic cell death at low external concentrations or by pseudo� apoptosis at high concentrations (5). These cell death modali� ties are both linked to the amount of drug taken up by the electroporated cells (6) and to the drug ability to make single and, mainly, double�strand DNA breaks, but result in very different evolutions of the tumor cells in vivo (7) . It is also possible to destroy tumor masses and obtain cures in mice bearing transplanted tumors by means of a large number of electric pulses of larger field amplitude, in the absence of any cytotoxic drug. This method is termed IRE (for Irreversible Electroporation) and it also ablates the normal tissues.
Over the last two decades, the clinical applications of ECT have been developed. During phase I/II clinical trials of can� cer patients with cutaneous and subcutaneous lesions of any origin, the efficacy of the treatment was confirmed by both CT scans and biopsies (8) . ECT is nowadays used in routine in the European Union to treat cutaneous and subcutaneous lesions. Recently the first use of ECT to cure a deep inextir� pable liver lesion was published (9).
Non�invasive imaging methods may detect tumor modifica� tions at early stages after treatments such as ECT, with better temporal resolution than histology. Diffusion�weighted imag� ing probes the mean displacement of the water molecules in biological tissues (10). The resulting net diffusion of the water molecules is referred to as the apparent diffusion coef� ficient (ADC). The ADC has been measured in many tumors at lower values than in the corresponding organs (11, 12) , and found correlated to tumor cellularity (13, 14) . Many studies established that ADC is a sensitive index to follow the early response to chemotherapeutic treatments (15�22).
The transverse relaxation time (T 2 ) is another sensitive, but not specific index that often reflects physiological and patho� logical tissue modifications (23, 17, 19) and has also been used to monitor the evolution of tumors (24). The longitudi� nal relaxation time (T1) also may reflect tissue modifications induced by therapies (15).
Since MRI give access to many parameters within one session, multiparametric examinations have been performed to moni� tor the tumor response to various therapies, combining ADC measurements, spectroscopy and dynamic contrast enhanced imaging that characterizes microvascularisation (16, 17) .
In the present work, the early modifications of ADC, T 2 and tumor volume of a LPB fibrosarcoma xenografted on syn� genic mice were studied at early times after application of three non thermal therapies based upon electric field pulses, namely electrochemotherapy with a normal or a high dose of bleomycin, and irreversible electroporation. The tumor model used in the experiments here reported, the treatment protocols applied and the consequences of these treatments at the cell and tissue levels have been previously explored and analyzed by histological studies done by our group, during in vitro (18) and in vivo (7) studies on electrochemotherapy using normal and high doses of bleomycin, and in vivo stud� ies (19) on the irreversible electroporation.
Materials and Methods

Mice
Forty C57Bl/6 mice 6�8 weeks old underwent a dorsal graft of LPB fibrosarcoma cells, which are a clonal derivative of a cell line derived from a methylcholanthrene�induced in a C57B1/6 mouse (20) . Cells were cultured in MEM (Gibco BRL, Cergy�Pontoise, France) using standard procedure. One million cells were injected subcutaneously in the dorsal flank of C57Bl/6 mice (19) . A tumor of 4 to 9 mm diameter was developed fourteen days later.
During the tumor treatment and the MRI procedure, mice were anaesthetized with 1.5% isoflurane in 1 L/min air administered through a nose cone.
During MRI, mice body temperature was maintained by blowing warm air through the magnet bore and by setting the gradient insert temperature at 268C.
The studies were conducted following the recommendations of the European Convention for the Protection of Vertebrates Animals used for Experimentation.
Treatment Protocols
Three control groups and three treated groups were studied, with 6 mice in each group.
The following N, E and B control groups were analyzed: group N received no treatment, group E underwent only the electrical protocol designed for ECT (4) and group B under� went only the injection of bleomycin (BLM) at a normal dose (0.4 mg/kg).
The following BE, HBE and IRE treated groups were stud� ied. Group BE was treated according to previous ECT protocols (4), receiving successively a BLM normal dose injection (0.4 mg/kg) and the electrical treatment for reversible electropermeabilization. Group HBE received successively a BLM high dose injection (80 mg/kg) and the electrical treat� ment for reversible electropermeabilization (4, 7). Group IRE was treated in the absence of BLM by a higher voltage and a higher number of electric field pulses following a protocol previously established and biologically evaluated (19) . Here the opening of cellular membrane was permanent and non reversible (19) .
Group N was monitored before, 24 and 48 hrs after the day of the treatment of the other groups. Groups B, E and BE were examined before, 3, 24 and 48 hrs after the respective treatment. For groups HBE and IRE, additional measure� ments were performed 1, 6 and 10 hrs after the treatment since it was known that these two treatments induce rapid tissue modifications (19, 21) . In four mice of the HBE group, the tumor was no more visible at 48 hrs. Therefore the HBE group measurements at 48 hrs were not taken into account in the final analysis.
For group IRE, the study was stopped 24 hrs after the treat� ment, since this treatment destroys all cells within 48 hrs after the treatment (19).
ECT Protocols
Bleomycin (Roger Bellon, Neuilly, France) dissolved in saline solution was injected in the retro�orbital sinus at a dose of 0.4 or 80 mg/kg in 100 µL (for the normal or high dose respectively). Four minutes after, the electric pulses, gener� ated by a GHT 1287 electropulsator (Jouan, St Herblain, France) were delivered by two flat stainless steel electrodes (10 mm long and 7 mm wide) laid on opposite sides of the tumor. Good contact between the electrodes and the previ� ously shaved skin was assured by means of a thin layer of conductive echographic gel (PMA, Aubervilliers, France) (22). For the normal electric pulses treatment (groups BE and HBE), eight square�wave electric pulses of 100 µs dura� tion were delivered to the tumor at a repetition frequency of 1 Hz. The electric field intensity, evaluated as the ratio of the applied voltage to the distance between the electrodes, was 1250 V/cm. For the irreversible electrical treatment (group IRE), an incision was performed on the skin near the tumor and the skin flap containing the tumor was lifted, taking particular care to avoid cutting the main blood ves� sels nourishing the tumor. The electrodes were placed in direct contact with both opposite sides of the sub�cutaneous tumor, in order to ensure the treatment of the whole volume, and to avoid skin necrosis, pain and infection during the follow�up.
Eighty square�wave electric pulses were then applied to the tumor in four sets of 20 pulses of 100 µs duration delivered at a repetition frequency of 0.3 Hz along four successive orientations (19) . The electric field intensity was 2500 V/cm (19) so that small tumors with dimensions 4�5 mm had to be selected for this group.
MRI Protocol
MRI examinations were performed with a 4.7 Tesla, 40 cm diameter, horizontal bore magnet (Oxford, UK) interfaced to a spectrometer Apollo (Tecmag, Houston, Texas). The mice were laid in prone position inside a home built bird�cage coil. A sealed water tube (inner diameter 5 mm, length 20 mm) was placed near the tumor to monitor the local temperature by water ADC measurements. Since echo planar imaging (EPI) used for diffusion measurements is highly sensitive to local magnetic field gradients, a thick alginate layer was applied around the tumor and the water tube, in order to increase the magnetic field homogeneity across the tumor.
The tumor volume measurement was made by using a T 1 �weighted spin�echo sequence with the following param� eters: repetition time (TR) 5 600 ms, echo time (TE) 5 5 ms, field of view (FOV) 5 50 mm 3 25 mm, matrix 5 256 3 128, 4 averages and seven contiguous axial slices of thickness 2 mm. A single axial slice was then selected in order to mea� sure local T 2 and ADC values through the larger section of the tumor and the water reference tube.
The ADC maps were obtained from acquisitions using a one�shot blipped spin�echo EPI diffusion weighted sequence with the following parameters: TR/TE 5 4.2 s/40 ms, FOV 5 50 mm 3 25 mm, acquisition matrix 5 128 3 48, spectral width 5 286 kHz, slice thickness 3 mm.
The diffusion gradient duration (δ) was 4.1 ms and the inter� val between the two diffusion gradient pulse centers (Δ) was 7.15 ms. The gradients of diffusion were applied simultane� ously along the three directions (read, phase and selection) to measure the trace of the diffusion tensor (23).
The diffusion weighting factor, b, defined by the equation:
where γ is the gyromagnetic ratio and G is the gradient diffu� sion intensity, was set at the successive values of 0, 33, 134, 300, 534, 835 and 1010 s/mm 2 .
To get rid from cross terms between imaging and diffusion gradients, four images were acquired at each b value by cycling the polarity of the diffusion gradient (24) along the read and phase directions. A presaturation slab was applied upon the mice belly to suppress the signal of the region that would contaminate the relevant image through residual ghosting (25). The T 2 maps were obtained thanks to a multi�echo sequence with the following parameters: TR 5 3 s, 4 echoes at successive echo times 10, 20.6, 31.2, 42.8 ms, FOV 5 40 mm 3 40 mm, matrix 5 256 3 128, slice thickness 3 mm.
All the MR acquisitions were performed at each examination time, but the tumor volume determinations that were omitted at 1h and 3 h after the tumor treatment.
Data Analysis
The tumor volume was evaluated from T 1 �weighted images by using imageJ (W. Rasband, NIH, USA). We determined the number of pixels in each slice through the tumor (2D sur� face). The tumor volume (V t ) was calculated as follow:
where A n is the number of pixel of the tumor in the slice n, ps is the pixel area and st is the slice thickness.
The diffusion�weighted and T 2 �weighted images were analy� sed with dedicated software written under MatLab (Math� Works, Natick, MA).
T 2 maps were calculated pixel�by�pixel by adjustment of sig� nals at the four successive echoes. Signals registered at each echo time were fitted to an exponential decay described by:
where TE is the echo time and T 2 is the transverse relaxation time, S (TE) is the signal intensity at the time TE, S 0 is the signal extrapolated at TE 5 0.
A ROI was manually drawn inside the tumor, and mean and standard deviation values of the T 2 were then calculated for this tumor ROI.
The apparent diffusion coefficient was derived from echo� planar images at different b values as follows:
The four diffusion weighted images acquired at each b value by cycling the gradient polarities were geometrically averaged, so to obtain one image at each b value, and then were corrected for electronic noise (26). At the lower b values, the vascular flow brought a significant contribution to the diffusion weighted sig� nal attenuation, reflecting tumor microvascularisation (27). The fit of ADC was then obtained from images at the four higher b values (300, 534, 835, 1010 s/mm 2 ), in order to reflect mostly the diffusion coefficient of the extravascular water.
The maps of ADC were computed by fitting signals of these four images on a pixel�by�pixel basis to the equation:
where S (b) and S 0 are the MR signal intensities with and without diffusive attenuation, respectively, and b is the diffu� sion weighting factor.
Mean and standard deviation of the ADC values were calcu� lated for a ROI inside each tumor, carefully drawn to avoid the inclusion of non tumoral tissue: First, a large ROI around the tumor and the peri�tumoral tissue was drawn, and the ADC map was calculated. Then, on this map, a smaller ROI, smaller than the true tumor section, was drawn avoiding con� tamination by the higher ADC of the peritumoral tissue.
The water ADC was also measured in the water tube. The mean ADC value in each tumor (ADC tumor ) was divided by the mean water ADC measured in the adjacent reference tube (ADC water ), in order to eliminate the influence of the small temperature variations between successive examinations and to calculate a normalized ADC (ADC norm ):
Statistical Analysis
Statistical analyses were done with NCSS�2007 (NCSS, Kaysville, Utah, USA). Tumor volumes were compared by paired Student's t�test analysis: in each group, the last val� ues determined at 24 or 48 hrs (according to the group) were compared to the initial values before treatment.
For T 2 and ADC mean values in tumors, multiple statisti� cal comparisons were performed, i.e. all the measurements at each time were compared to those at other times, using Fisher's LSD t�test corrected for multiple comparisons. The differences between groups were assessed as significant for p , 0.05. Detailed p values are given in the Tables I to III .
Results
The tolerance of treatment was good for all mice. In 4 mice of group HBE the tumor volume decreased so quickly that no measurement could be done at 48 hrs. Data for this group at 48 hrs were not taken into account for statistical evaluation.
T 1 �weighted images of the slice corresponding to the tumor center, EPI images at b 5 0 and corresponding ADC maps for one mouse of group BE, before and at 24 hrs after treat� ment, are shown in Figure 1 .
The mean values of volume, T 2 and ADC of the tumors, at each examination time and for each group of mice, are reported on Tables I, II and III respectively. The variations of the mean normalized tumor ADC are displayed in Figure 2 .
The tumor volumes before the treatments were similar between all groups except group IRE. In the group IRE, the tumor volume before treatment was smaller (119 6 47 mm 3 ) compared to 347 6 280 mm 3 in the other groups. Indeed, the electropulsator used could not deliver more than 1500 volts, thus limiting the tumor diameter to 5�6 mm to obtain the elec� tric field needed for the IRE therapy. 
Table III
Mean tumor ADC before the treatment (0 hr) and at 1, 3, 6, 10, 24 and 48 hrs after the treatment (depending on the group). No ADC measurement was done in group HBE since 4 tumors were no more detectable and one was so small that contamination by adjacent structures was unavoidable. The tumor volume increased significantly (p , 0.05) for each of the control groups (N, B and E) at 48 hours after the treatment.
It decreased significantly at 24 hrs after the treatment for groups HBE (238%, p , 0.03) and IRE (227%, p , 0.05).
In group BE, a non significant decrease (p 5 0.09) of tumor volume was observed 48 hrs after the ECT treatment.
No significant variation in the mean tumor T 2 was observed in groups E, N and BE after the treatment. The mean tumor T 2 of group B increased significantly (p , 0.03) between 3 and 24 hrs after the treatment. In group IRE, the mean tumor T 2 increased significantly between 1 and 6 hrs after the treat� ment. The mean tumor T 2 increased significantly in group HBE at all the times after the treatment, and reached a maxi� mum at 10 hrs after the treatment.
No significant correlation was observed between the mean ADC at time zero and the tumor volume (R 2 5 0.05, p 5 0.19). This model of tumor has a slow growth without rapid central necrosis (20) .
No significant variation in the mean tumor ADC was observed at any time in groups E and N. The mean tumor ADC of group B decreased significantly 24 hrs after the treatment compared to the value at 3 hrs (p , 0.03). A, B) , echo�planar images at the lowest diffusion weighting (b 5 0) at second row (C, D) and ADC maps at third row (E, F), respectively. The echo�planar images are strongly T 2 �weighted since they are obtained at echo time 40 ms. White arrowheads indicate the tumor; white arrows indicate the water tube. Black arrows indicate the oedema after treatment. White dotted arrows indicate the low signal alginate layer laid to improve magnetic field homogeneity. The tumor is clearly delineated on the T 1 �weighted images. On the images obtained 24 hrs after the treatment, a hypo�intense signal on the T 1 �weighted image (B) and a hyper�intense signal, (black arrow) on the T 2 �weighted echo�planar image (D) correspond to oedema in the subcutaneous tissue caused by the ECT. The shape of the tumor is simi� lar in the echo�planar images and the T 1 �weighted images, indicating weak distortions of the static magnetic field, while the water tube not affected by shim� ming exhibits geometrical distorsions. The ADC maps show clear differences between the tumor tissue (in blue), the post�treatment oedema (in red, indicated with a black arrow) and other tissues such as muscle (in green/yellow) and the tumor ADC increase is seen from image E to F.
The mean tumor ADC increased significantly at 24 hrs after the treatment (117.6%, p , 0.03) in the BE group.
The mean tumor ADC increased significantly at 10 hrs after the treatment (119%, p , 0.03) in the HBE group.
In group IRE, the mean tumor ADC decreased significantly at 1 hr and 3 hrs after the treatment and later was higher at 24 hrs than at 3 hrs.
Discussion
Our group previously investigated the histological changes occurring in cells and tumors treated by various electropora� tion�based approaches as described in particular in vitro by Tounekti et al. in 1993 and 1995 (5, 18) and in vivo by Mekid et al. in 2003 (7) and Al Sakere et al. in 2007 (19) . The pres� ent work investigates the relationship between, on the one hand, the variations of volume, T 2 and ADC in tumors moni� tored in vivo by MRI and on the other hand, the tissue modi� fications known, from our previous studies (5, 7, 18, 19) to be caused by the various electroporation�related treatments explored in this work.
Several issues had to be addressed before we could acquire the data necessary to fulfil the comparison between the MRI data and the previous histological data.
An important issue was related to the fact that ADC mea� surements on living structures suffer from every kind of physiological motion. Tumors were implanted in the lower back, a region nearly devoid of respiration motions, which were further reduced by the alginate layer spread around the tumor. The choice of a single shot EPI diffusion weighted sequence resulted in very fast imaging, with acquisition time 53 ms, almost freezing any physiological motion during each acquisition.
In another respect, on the diffusion images, it is critically important to correctly delineate the tumor ROI for the correct measurement of the tumor ADC without a contamination by adjacent structures. In order to validate the ROI determina� tion for the tumor ADC measurements, a test of inter�observer reproducibility was performed upon ten tumors by two authors LC and AL�W. The coefficient of variation between the mean ADC values was 1% (data not shown).
Conventionally, tumor response is assessed through the fol� low�up of the changes in tumor size after the treatment. In a recent study (28) Agerholm et al. treated by electrochemo� therapy glia�derived tumors transplanted in rat brain. They followed the tumors using contrast enhanced MRI before and from one to 24 days after the treatment, both in untreated and treated tumors. Therefore, the efficacy of the therapy was evaluated mostly through the tumor volume that started to decrease 4 days after the ECT. In our study, tumor volumes decreased significantly within the first 24 hours both after treatment with a high BLM dose (238%) and after treatment with an irreversible electroporation (227%). Conversely the decrease of tumor volume for the group treated with the vali� dated ECT clinical protocol (group BE) was not significant 48 hrs after the treatment, as expected for previous knowledge on the mechanism of mitotic cell death induction in tumors treated by ECT (7, 29) .
Generally, tumor treatment may induce several different cell modifications that induce different patterns of ADC and T 2 variations: cell swelling, cell death by apoptosis, necrosis or a mitotic catastrophe, and cell lysis (23, 30) .
Any modification of the water repartition between the intra� cellular and extracellular spaces is reflected by ADC varia� tions. Cell swelling observed after brain ischemia (31) and at short time intervals after some therapies by vascular dis� rupting agents (32), is detected by a rapid ADC decrease. Cell apoptosis causing the shrinking of the cells and of the cellular structures (for example the condensation of the chro� matin) results in the fact that water molecules can diffuse more freely, and ADC increases (30). Necrosis also induces ADC increase because of the disruption of the cells plasma membranes.
Vascular modifications in the treated areas have been described as the result of the delivery of these electropora� tion�based treatments. A local reduction of local blood flow, termed vascular lock, induced by the electric pulses with or The normalized ADC values were measured within each tumor before treat� ment and at times 3, 24, 48 hours, for the untreated groups (N, B, E) and the three groups that underwent the therapeutic protocols (BE, HBE, IRE). without drugs, has been demonstrated by several studies, in tumors (33, 34) as well as in normal tissues (35) . A stronger and more prolonged blood flow reduction was found using the IRE protocol (19) . It is interesting to discuss the relations between ours and others' MRI observations and the corre� sponding histological findings from these studies as some of them were actually performed using the same tumor model and the same protocols.
The absence of modification of T2 and ADC in tumors of groups N and E was as expected. Significant variations of T2 and ADC in tumors of group B were observed at 24 hrs after a single BLM injection at normal dose. These variations are probably related to the endothelial toxicity of BLM (36), inducing at 24 hrs modifications of T2 and ADC similar to those observed in the IRE groups at 1�3 hrs.
In the case of ECT at the normal BLM dose (0.4 mg/kg, equivalent to the clinically used dosage), the in vivo histologi� cal study of the same tumor under identical therapy by Mekid et al. (7) showed that normal mitosis were not detectable after the treatment, that the tumor cells became progressively larger and that the percentage of cells in apoptosis started to increase 25 hrs after the treatment. At a similar time, 24 hrs, we observed a strong ADC increase (117%) in the tumors of the group BE (BLM dose 0.4 mg/kg), in agreement thus with these previously reported histological findings. In this BE group, where the modifications caused by the treatment occur over several days, the evaluation of T 2 was probably per� formed too early after the treatment to permit the observation of T 2 changes. It is worth noting that in human patients with locally advanced breast tumors the overall decrease of the tissue water T 2 was reported after 2 cycles of neo�adjuvant chemotherapy (37).
In the case of ECT at a high BLM dose (50 mg/kg), the in vitro morphological analysis (18), and the in vivo histological study on the same tumor treated under identical conditions (7) showed a very rapid decrease in the fraction of cells in mitosis and a massive increase of the percentage of apoptotic cells (34.5 6 6.3%), a percentage 10 fold larger than that observed in control tumors: actually, the high doses of BLM entering the electropermeabilized cells cause a pseudo�apop� tosis due to the endonuclease activity of the BLM (7, 18). In our study, the ADC increase detected at 3 hrs in the HBE group (119%) is actually observed at the time of the occur� rence of this cell massive pseudo�apoptosis (18).
A significant increase in T 2 was detected in group HBE at 3, 6 and 10 hrs after the treatment. Very similar observations were made on Hep�2 tumors treated ex vivo by ECT using high BLM doses injected in the tumor (38). In the opinion of these authors, an early apoptosis and tumor cell death could explain these results. The accompanying loss of structural integrity would lead to a longer T 2 value, which we also observed.
In tumors treated by IRE, an evident congestion of blood in the tumor vessels (as soon as 5 min after the treatment), resulting from a massive vascular lock, was reported by Al�Sakere et al. (19) . Few changes in tissue architecture and cell morphology were detected 1 and 2 hrs later. IRE�caused tissue modifications, i.e. the progressive and complete disso� lution of the cells membranes, resulting in only one compart� ment, became dramatic at 6 hrs and later. These results are in accordance with the T 2 and ADC variations observed over 24 hours in our study.
IRE�caused tissue modifications have also been documented by Zhang and Guo in normal rat liver (39) and in a rat model of hepatocarcinoma (40). Very early after IRE of the liver, they observed signal modifications coherent with T 1 and T 2 increases (as we here report for T 2 values).
Actually, the T 2 evolution in the tumors of the IRE group reveals two successive phenomena, the decrease and then the increase of the T 2 after the treatment. As previously discussed, IRE induces a permanent reduction of the tumor blood flow termed vascular lock whereas after ECT, the vascular lock is partially reversible. The T 2 decrease at 1 hr after the treat� ment can thus be caused by the vascular lock, ischemia and cell swelling since the intracellular water T 2 is shorter than the extracellular value, and its contribution increases. Later on, the T 2 increase can be explained by the loss of the total� ity of the cellular membranes that result in the generation of one single water compartment, as the separation between the intra� and extra�cellular spaces is cancelled.
As described by many studies (23, 32, 38, 41�44) , the increase in ADC under therapy is an early marker of the efficiency of the treatment by chemotherapy. We observed an increase in the ADC values at 24 hrs after ECT with a normal BLM dose, and at 3 hrs after ECT with a very high BLM dose (which we assume is mainly due to the rapid cell pseudo�apoptosis caused by the high doses of bleomycin entering the permea� bilized cells (5)).
After the IRE treatment, the ADC decreased at 1 to 3 hrs, probably due to the swelling of cells induced by the isch� emia and to the vascular lock, taking place immediately after the treatment (23). Actually, an early and prolonged vascular lock which should contribute to this decrease of ADC was observed by Al�Sakere et al. (19) , as already quoted.
In this work, we show a very clear agreement between histological modifications and ADC and T 2 changes in tumors treated by ECT and by other electroporation�based approaches. Moreover, in some cases ADC and/or T 2 allowed to detect early and rapid changes in the treated tumor whereas the monitoring of the tumor volume, though precise, not yet detected variations shortly after the treatments. In our experi� ments, the ADC follow up was found to be more sensitive than that of T 2 , a finding coherent with other studies. It is also important to take into account the exact time at which the measurements of these parameters are performed, in order to optimize the early appreciation of the treatments efficacy.
